Who Owns XFOR?

X4 Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$4.13

+0.03 (+0.61%)

Market Cap

$48.0M

Shares Outstanding

11,408,300

Institutional Holders

3

Total Inst. Value

$1.7M

% of Float Held

109.0%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1KINGDON CAPITAL MANAGEMENT, L.L.C.$1.7M7,000,000
2PRICE T ROWE ASSOCIATES INC /MD/$20K83,015
3EverSource Wealth Advisors, LLC$730

Biggest Buyers & Sellers This Quarter

Top Buyers

FundShares AddedValue
KINGDON CAPITAL MANAGEMENT, L.L.C.+2.1M$1.7M

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold XFOR?

As of Q1 2025, 3 institutional investors report holding XFOR (X4 Pharmaceuticals, Inc.) in their 13F filings.

What percentage of X4 Pharmaceuticals, Inc. is owned by institutions?

Institutional investors hold approximately 109.0% of X4 Pharmaceuticals, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most XFOR?

The largest institutional holder of XFOR is KINGDON CAPITAL MANAGEMENT, L.L.C. with $1.7M in shares.

Are institutions buying or selling XFOR?

This quarter, 2 institutions opened new positions in XFOR and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.